Papers
22
Total Citations
485
H-Index
11
About
Dr. Boris Hadaschik is a leading urologic oncologist whose research focuses on refining surgical techniques for prostate and kidney cancers, with a particular emphasis on robotic-assisted procedures. His major contributions include comparative effectiveness studies that have shaped clinical practice, such as the MASTER study meta-analysis (83 citations) demonstrating the benefits of Retzius-sparing radical prostatectomy for urinary continence. He has also pioneered work on fluorescence-guided lymphography during extended pelvic lymph node dissection (47 citations) and investigated predictive factors for immediate continence after prostatectomy (44 citations). In renal surgery, Dr. Hadaschik has advanced the field through multicenter analyses comparing retroperitoneal versus transperitoneal robotic partial nephrectomy (53 citations) and evaluating outcomes for challenging endophytic tumors (50 citations). His research extends to perioperative chemoimmunotherapy for muscle-invasive urothelial carcinoma (32 citations) and surgical quality improvement, including the impact of surgeon experience on partial nephrectomy outcomes (28 citations). With over 2500 patients analyzed in multicenter studies, Dr. Hadaschik’s work consistently provides evidence-based guidance for optimizing surgical approaches and patient outcomes in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5Predictive factors for immediate continence after radical prostatectomy44 citations · 2015
- 6
- 7
- 8
- 9
- 10